Liu Qianmin, Song Simin, Liu Lu, Hong Wei
School of Biomedical Sciences, Hunan University, Changsha 410082, China.
Shenzhen Key Laboratory of Neuroimmunomodulation for Neurological Diseases, Shenzhen-Hong Kong Institute of Brain Science, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China.
Biomolecules. 2025 Apr 11;15(4):571. doi: 10.3390/biom15040571.
Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by extracellular plaques containing amyloid β-protein (Aβ) and intracellular neurofibrillary tangles formed by tau. Cerebral Aβ accumulation initiates a noxious cascade that leads to irreversible neuronal degeneration and memory impairment in older adults. Recent advances in Aβ seeding studies offer a promising avenue for exploring the mechanisms underlying amyloid deposition and the complex pathological features of AD. However, the extent to which inoculated Aβ seeds can induce reproducible and reliable pathological manifestations remains unclear due to significant variability across studies. In this review, we will discuss several factors that contribute to the induction or acceleration of amyloid deposition and consequent pathologies. Specifically, we focus on the diversity of host animals, sources and recipe of Aβ seeds, and inoculating strategies. By integrating these key aspects, this review aims to offer a comprehensive perspective on Aβ seeding in AD and provide guidance for modeling AD pathogenesis through the exogenous introduction of Aβ seeds.
阿尔茨海默病(AD)是一种进行性神经退行性疾病,其特征是细胞外存在含有β-淀粉样蛋白(Aβ)的斑块以及细胞内由tau蛋白形成的神经原纤维缠结。脑内Aβ的积累引发了一系列有害级联反应,导致老年人出现不可逆的神经元退化和记忆障碍。Aβ种子研究的最新进展为探索淀粉样蛋白沉积的潜在机制以及AD复杂的病理特征提供了一条有前景的途径。然而,由于各研究之间存在显著差异,接种的Aβ种子能够诱导出可重复且可靠的病理表现的程度仍不清楚。在这篇综述中,我们将讨论导致淀粉样蛋白沉积诱导或加速以及随之而来的病理变化的几个因素。具体而言,我们关注宿主动物的多样性、Aβ种子的来源和配方以及接种策略。通过整合这些关键方面,本综述旨在提供关于AD中Aβ种子接种的全面观点,并为通过外源引入Aβ种子模拟AD发病机制提供指导。